← All trials
NCT04949867
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 20, 2021
- Primary completion
- Jun 1, 2022
- Completion date
- Apr 1, 2023
- First posted
- Jul 2, 2021
- Last posted
- Jul 12, 2021
- Enrollment
- 20
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Steno Diabetes Center CopenhagenLead sponsor
- University of CopenhagenCollaborator
- Technical University of DenmarkCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.